{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-104379","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.084880+00:00","generated_at":"2026-05-17T01:29:07.450126+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Owens & Minor to sell Products & Healthcare segment; Q3 adjusted EPS $0.25","bullets":["Signed definitive agreement to sell Products & Healthcare Services segment, pivoting to pure-play home-based care.","Q3 continuing ops revenue $697.3M (+1.5% YoY); GAAP loss ($0.07)/share; adjusted EPS $0.25.","Adjusted EBITDA from continuing ops $92.2M in Q3, down 14% YoY; YTD adjusted EBITDA $284.8M up 6%.","Announced nationwide preferred provider partnership to expand home-based care reach.","Transaction expected to simplify capital deployment and focus on Patient Direct growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-104379","json":"https://secwatch.observer/filing/0001104659-25-104379.json","markdown":"https://secwatch.observer/filing/0001104659-25-104379.md","text":"https://secwatch.observer/filing/0001104659-25-104379.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000110465925104379/0001104659-25-104379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000110465925104379/omi-20251030x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:29:07.450126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}